The Discounted Cash Flow (DCF) valuation of Entia Biosciences Inc (ERGO) is (1.71) USD. With the latest stock price at 0.00 USD, the upside of Entia Biosciences Inc based on DCF is -1711820.1%.
Based on the latest price of 0.00 USD and our DCF valuation, Entia Biosciences Inc (ERGO) is a sell. selling ERGO stocks now will result in a potential gain of 1711820.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 3.0% - 5.1% | 4.0% |
| Long-term Growth Rate | 2.0% - 2.7% | 2.4% |
| Fair Price | (11.17) - (0.95) | (1.71) |
| Upside | -11166108.9% - -952938.1% | -1711820.1% |